###### T R A N S F U S I O N  P R A C T I C E

 A pilot randomized trial comparing symptomatic vs. hemoglobin-
#### level-driven red blood cell transfusions following hip fracture

###### J.L. Carson, M.L. Terrin, F.B. Barton, R. Aaron, A.G. Greenburg, D.A. Heck, J. Magaziner, F.E. Merlino, G. Bunce, B. McClelland, A. D u n and H. Noveck

n 1992, over 11 million units of red cells (RBCs) were
transfused in the United States.’ Each unit of RBCs is

**BACKGROUND: The indications for transfusion have**

estimated to cost about $150 to $200, for a total an-

never been evaluated in an adequately sized clinical

nual expenditure of approximately $2 billi~n.~-~ Most

trial. A pilot study was conducted to plan larger clinical

RBC I transfusions are given to surgical patients. While there

trials.

is extensive literature documenting the risks associated

**STUDY DESIGN AND METHODS: Hip fracture patients**

with tran~fusion,~*~ much less is known about the indica-

undergoing surgical repair who had postoperative hemo-

tions for transfusion and the benefits of transfusion in the

globin levels less than 10 g per dL were randomly as-

perioperative setting.

signed to receive 1) symptomatic transfusion: that is,

In five small randomized clinical trials that contrasted

transfusion for symptoms of anemia or for a hemoglobin

transfusion thresholds, no differences were observed be-

level that dropped below 8 g per dL or 2) threshold

tween transfusion groups,’-” except for the finding in one

transfusion: that is, patients receive 1 unit of packed

study of delayed myocardial recovery in patients with lower

RBCs at the time of random assignment and as much

hemoglobin (Hb) level^.^ However, the largest of these tri-

blood as necessary to keep the hemoglobin level above

als included only69 patients. An observational cohort study

10 g per dL. Outcomes were 60-day mortality, morbidity,

of 1957 surgical patients who refused blood transfusion for

functional status, and place of residence.

religious reasons suggests that mortality in surgical patients

**RESULTS: Among 84 eligible patients enrolled, mean**

starts to increase at Hb levels below 10 g per dL; patients

(&D) prerandomization hemoglobin was 9.1 (* 0.6) g/

with cardiovascular disease had higher mortality with ane-

dL. The median number of units transfused in the

mia than those without cardiovascular disease. A retrospec-

threshold transfusion group was 2 (interquartile range, =

tive cohort study of 8787 hip fracture patients found no

1 -2), and that in the symptomatic transfusion group was

association between postoperative transfusion and 30- or

0 (6; interquartile range, = 0-2) (p<O.OOl). Mean hemo-

90-day mortality.13

globin levels were approximately 1 g per dL higher in the
threshold group than in the symptomatic group: for ex-
ample, on Day 2, 10.3 (* 0.9) g per dL versus 9.3 (* 1.2)

**ABBREVIATIONS: ASA =American Society of Anesthesiologists;**

g per dL, respectively (p<O.OOl). At 60 days, death or in-

**CDC = Centers for Disease Control and Prevention; Hb = hemo-**

ability to walk across the room without assistance oc-

**globin; MI = myocardial infarction; RBC(s) = red cell(s).**

curred in 16 (39.0%) of the symptomatic transfusion

**From the Division of General Internal Medicine, Department of**

group and 19 (45.2%) of the threshold transfusion

**Medicine, University of Medicine and Dentistry of New Jersey,**

group. Death occurred by 60 days in 5 (1 1.9%) of the

**Robert Wood Johnson Medical School, New Brunswick, New Jer-**

symptomatic transfusion group and 2 (4.8%) in the

**sey; the Maryland Medical Research Institute, and the Depart-**

threshold transfusion group (relative risk = 2.5; 95% CI,

**ment of Epidemiology and Preventive Medicine, University of**

0.5-12.2). Other outcomes were similar for the two

**Maryland, Baltimore, Maryland; the Department of Surgery,**

groups.

**Miriam Hospital, Providence, Rhode Island; the Department of**

**CONCLUSIONS: Symptomatic transfusion may be an ef-**

**Orthopaedic Surgery, Indiana University, Indianapolis, Indiana;**

fective blood-sparing protocol associated with the transfu-

**and the Department of Transfusion Medicine, University of**

sion of appreciably fewer units of RBCs and lower mean

**Edinburgh, The Royal Infirmary of Edinburgh, Edinburgh, Scot-**

hemoglobin levels than are associated with the threshold

**land.**

transfusion policy. However, it is unknown whether these

**Received for publication September 26, 1997; revision re-**

two clinical strategies have comparable mortality, morbid-

**ceived December 8,1997, and accepted December 22,1997.**

ity, or functional status. A definitive trial is needed.

~~ **TRANSFUSION 1998;38:522-529.**

**522** **TRANSFUSION** Volume 38, June 1998


-----

As a preliminary step in evaluating the clinical benefit domization and as much additional blood as needed to
of transfusion, we conducted a pilot study for a randomized keep the Hb level above 10 g per dL during the hospital
clinical trial comparing two transfusion strategies. The admission.The symptomatic transfusion strategy required
goals of this pilot study were to demonstrate 1) that recruit- that transfusion be delayed until the patient developed
ment of an elderly population of patients with hip fracture symptoms or experienced consequences of anemia, but
was feasible, 2) that the study protocol could be imple- transfusion was permitted in the absence of symptoms if
mented and would result in different mean Hb levels and the Hb level fell below 8 g per dL. If transfusion was given
numbers of units transfused in the groups, and 3) that fol- for symptoms of anemia, enough blood was given to relieve
low-up for mortality, place of residence, and functional sta- the symptoms; if transfusion was given because the Hb level
tus could be completed. fell below 8 g per dL, enough blood was given to increase

the Hb level above 8 g per dL. Postrandomization Hb level
evaluations were performed at least twice in all patients and

###### METHODS AND MATERIALS

as clinically indicated.

**Study deslgn and study population** Symptoms and consequences of anemia were defined
We performed a randomized clinical trial in hip fracture as chest pain thought to be cardiac in origin; myocardial
patients who underwent surgical repair from March 1996 infarction (MI); congestive heart failure; unexplained
to March 1997. All patients presenting for hip fracture re- tachycardia, hypotension, or decreased urine output that
pair were assessed for eligibility for the study. Patients were was unresponsive to fluid replacement; and poor rehabili-
eligible for the trial if their Hb levels were less than 10 g per tation, defined as inability to get out of bed for rehabilita-
dL in the immediate postoperative period, defined as the tion by the third postoperative day.
time from the end of anesthesia in the operating room to
11:59 PM 3 days after surgery (counted from 12:OO midnight **Outcomes**
on the first day after surgery). Hb levels were measured on **_primary outcome.The outcome of most interest was death_**
each of the first three postoperative days to identify eligible within 60 days of the operative procedure or the inability
subjects. Patients who refused transfusion because of reli- to walk 10 feet or across a room without human assistance
gious beliefs, suffered multiple trauma (defined as any in- 60 days after surgery. These possible outcomes were cho-
jury that required surgical repair in addition to the hip frac- sen because the main objective after hip fracture surgery
ture), or had symptoms of anemia were excluded from the is to restore function, and Hb levels may be important to
trial. patient recovery. Information about walking ability was
The study was performed at RobertWood Johnson Uni- ascertained by telephone interviews. If the patient could
versity Hospital, a 491-bed university hospital located in not be interviewed directly, information was obtained from
New Brunswick, NJ; St. Peters Medical Center, a 450-bed either a family member or health care provider.
university-affiliated hospital also located in New Brunswick Secondary outcomes. Secondary outcomes were 30-
Miriam Hospital, a 247-bed university-affiliated hospital and 60-day mortality, place of residence at 60 days, func-
located in Providence, RI; and The Royal Infirmary of tional status at 60 days, in-hospital myocardial infarction,
Edinburgh (for only 1 month), an 828-bed university hos- thromboembolism, stroke, and pneumonia. Residence sta-
pital located in Edinburgh, Scotland. The Edinburgh site tus for the patients were classified as follows: community
was added at the end of recruitment and was included in dwelling (home alone, home with others), retirement home
the evaluation of treatment outcome but not in the evalu- (e.g., sheltered housing, congregate housing, halfway
ation of recruitment experience. In accordance with the house, or board and care facility), nursing home (e.g.,
principle of intention to treat, all randomly assigned pa- skitled-nursing facility, intermediate-care facility, extended-
tients are counted in treatment comparisons. Random care facility), or other.
treatment allocation and ongoing monitoring of enrollment We assessed functional status with questions designed
were managed on an automated telephone-response sys- to evaluate lower extremity function after hip fracture.14J5
tem at the Maryland Medical Research Institute (Baltimore, The activities queried were 1) getting in and out of bed, 2)
MD). Institutional review board or an ethics committee walking 10 feet or across the room, 3) walking one block on
approved the study at each institution. level sidewalk, 4) climbing five stairs, 5) getting into and out

of a car, 6) rising from an armless chair, 7) putting on pants,

**Transfuslon strategies** 8) putting socks and shoes on both feet, 9) getting in and
Eligible patients who gave informed consent (or, for those out of bath or shower, and 10) taking a shower, bath, or
not mentally competent, whose relatives gave informed sponge bath. For each task, patients were classified as re-
consent) were randomly assigned to one of two transfusion quiring no help, requiring the use of equipment only, requir-
strategy groups. The threshold transfusion strategy required ing human assistance (with or without equipment), or be-
patients to receive 1 unit of packed RBCs at the time of ran- ing unable to perform the task for health reasons. Any

Volume 38, June 1998 **TRANSFUSION** 523


-----

patient who died within the first 60 days was classified as **Data collection**
being unable to perform the task for health reasons. If the Study nurses abstracted data primarily from the patients’
patient did not perform the task for reasons other than medical records and the administered study question-
health or was unable to accurately define the level of assis- naires. Additional information was obtained from the pa-
tance needed, the score for that specific task was treated as tients’ physician(s) as needed. Chronic lung disease was
missing. defined by a history, chest radiograph interpretation, or
Postoperative MI was defined as definite if the patient pulmonary function test consistent with chronic obstruc-
had positive CK-MB enzymes, if an electrocardiogram was tive pulmonary, chronic bronchitis, emphysema, or restric-
interpreted locally as consistent with a MI, or if there was tive lung disease. Diabetes mellitus was defined by a his-
postmortem evidence of an acute MI. MI was defined as tory of diabetes mellitus treated with oral medication or
possible if the patient had chest pain and an electrocardio- insulin. Dementia or confusion was defined by a prefracture
gram interpreted as consistent with possible new MI. history of confusion, disorientation, global intellectual im-
Thromboembolism was defined as deep venous pairment, or memory loss.
thrombosis confirmed by duplex ultrasound, impedance The type of hip fracture was classified as femoral neck
plethysmography, venogram, or postmortem examination (subcapital, cervical, midcervical, transcervical, intracapsu-
or as pulmonary embolism confirmed by a high-probabil- 1x1, intertrochanteric (basilar, basicervical, pertrochanteric,
ityventilation-perfusion scan, or pulmonary angiogram, or or extracapsular), or subtrochanteric (proximal femur).The
postmortem examination.16-” American Society of Anesthesiologists (ASA) physical sta-
Stroke was defined as definite if there. was evidence of tus assessment was recorded.z3~24Thromboem-bolism pro-

phylaxis was classified as warfarin, low-molecular-weight

a new hemorrhage or infarction on a magnetic resonance

heparin, intravenous heparin, or subcutaneous heparin

image study, CT scan of the head, or autopsy. Stroke was

(10,000-30,000 unitslday), pneumatic compression stock-

defined as possible if there was an unsupported physician

ings, or aspirin.The type of thromboembolism prophylaxis

diagnosis of neurologic deficit.

was chosen by the attending physician. We recorded the

We used a modified Centers for Disease Control and

number of blood transfusions during the preoperative, intra-

Prevention (CDC) case definition of pneumonia22: chest ra-

operative, and postoperative periods; the last preoperative

diograph with new or progressive infiltrate, consolidation,

Hb level; and the postoperative Hb levels.

or cavitation and any of the following: new onset of puru-

Data collection was completed with a telephone inter-

lent sputum or change in character of sputum, or the iso-

view 60 days after. Study nurses, blind to the transfusion

lation of the organism from blood culture, transtracheal

status of the patient, obtained information from patients or

aspirate, bronchial brushings, or biopsy. We did not con-

proxies on survival, place of residence, and functional sta-

sider a patient with rales and purulent sputum to have

tus.

pneumonia, nor did we use pleural effusion in our chest
radiograph definition.

**Statistical analysis**
We performed all the analyses using the intention-to-treat

**Randomization**

principle. Patient characteristics were compared by using

Study personnel at the clinical sites randomly assigned

tests for homogeneity of proportions for categorical vari-

patients by contacting the data coordinating center’s 24-

ables and the l test to test for differences in mean (* SD) or

hour automated telephone service. Randomization sched-

Wilcoxon’s rank sum test for distributions represented by

ules were stratified by clinical site and cardiovascular dis- median and interquartile ranges. Relative risk and 95% CI
ease status; the randomization was designed in blocks of were calculated by standard methods.
two to eight patients to avoid imbalance within a site. Bal-
anced randomization of patients with cardiovascular dis-

###### RESULTS

ease was deemed important because prior data suggested
that patients with cardiovascular disease may not tolerate There were 192 eligible hip fracture patients admitted to the
anemia as well as patients without cardiovascular disease. l2 three US study hospitals. We obtained consent from 143
Cardiovascular disease was defined by a history of (74%) of these patients. Ninety-six (67%) of these 143 pa-
ischemic heart disease (MI, angina pectoris, or evidence of tients had a Hb level less than 10 g per dL in the immediate
coronary artery disease) or by an electrocardiogram with postoperative period. We randomly assigned 80 (83%) of the
evidence for previous MI, history or presence of congestive 96 patients40 in each of the two treatment groups. The
heart failure, chest radiograph consistent with congestive reasons for not enrolling the remaining 16 patients were
heart failure, history or presence of peripheral vascular dis- that the attending physician declined to permit random
ease, or history of stroke or transient ischemic attack. assignment of 14 patients, one patient had been randomly

524 TRANSFUSION Volume 38, June 1998


-----

assigned within the previous month, and one patient was population had a mean age of 82.3 (k9.5) years and was pre-
withdrawn by the spouse. We recruited 42 percent of eligible dominatelywhite and female (Table 1). Cardiovascular dis-
hip fracture patients at the US study sites (Fig. 1). In addi- ease was present in 45.2 percent and a history of dementia
tion, 4 (9.8%) of 41 patients were enrolled in Edinburgh: 2 or confusion in 35.7 percent. Most patients had intertro-
patients were randomly assigned to each of the two treat- chanteric fractures (65.5%) and underwent general anes-
ment groups. thesia (60.7%). The mean prerandomization Hb level was
Of the 84 enrolled patients, 3 refused to comply with 9.1 g per dL (k 0.6). The two groups were similar in these
the study protocol after randomization, although follow-up baseline characteristics.
was completed at 60 days. The assigned transfusion strat- The median number of units transfused differed in the
egy was successfully implemented in 93.8 percent (76181) `two transfusion groups: in the threshold transfusion group,`
of the remaining patients. One patient in the threshold it was 2 (maximum of 4, interquartile range = 1-21, and in
transfusion group did not receive a transfusion, and four the symptomatic transfusion group, it was 0, (maximum of
patients in the symptomatic transfusion group received a 6, interquartile range = 0-2), p<O.OOl (Table2). Nineteen pa-
transfusion in violation of the protocol (i.e., they did not tients (45.2%) in the symptomatic transfusion group re-
have symptoms of anemia or a Hb of **_c8 gldL). Sixty-day_** ceived transfusion(s) .
follow-up was obtained in all patients. The overall study The lowest mean Hb level after randomization in the

symptomatic transfusion group was 8.75 g per dL (SD f 1.2:
range, 5.6-11.4 gldL). The highest
mean Hb level in the threshold trans-
fusion group was 11.1 g per dL (SD f

Eligible patients `0.9: range, 8.6-14.0 gldL). Mean daily`
**192**

Hb levels in the transfusion groups
differed by approximately 1 g per dL
from the time of randomization until

Consent obtained

discharge from the hospital (Fig. 2).

**143 (74%)**

### 1 Sixty days after randomization,

16 (39.0%) patients in the symptom-
atic transfusion group and 19 (45.2%)

**Hb < l o gldt**

in the threshold transfusion group

**96 (67%)**
**I** I were dead or could not walk across

the room or 10 feet without human

Randomly Assigned assistance (relative risk = 0.9,95% CI
`80 (83%)` 0.5-1.4, p = 0.57) (Table 3). Five

(11.9%) patients in the symptomatic

transfusion group and two (4.8%) in

Threshold transfusion protocol implemented (n.37) Symptomatic translusion protocol implemented the threshold transfusion group were

Protocol violation (n.1) Protocol violation (n.4) dead at 60 days (relative risk = 2.5;

Withdrew lrom hospital pad of study (n.2) W ithdrew from hospital pad of study (n.1) 95% CI, 0.5-12.2: p=0.43). Residence

in a nursing home and length of hos-
pital stay were similar in the groups.

Follow-up (11.40) Followup (11.40) Morbid events were uncommon
## r-5 r-5

(Table 3). There were no appreciable
differences in outcomes in patients

Withdrawn (n.0) Withdrawn (n.0) with and without cardiovascular dis-

ease.
Many patients had important
limitations in function at 60 days

Completed Trial (n= 40) ICompleted Trial (n=40 )I

(Table 4). Only 57.8 percent of pa-
tients could walk across the room or
10 feet, and 51.8 percent could get in

**Fig. 1. Trial proflle for US portion of the study. Overall, 42 percent of eligible patients**

and out of bed without the assistance

**were randomly assigned. The three patients who withdrew from the hospital part of**

of another person.

**the study permitted telephone follow-up at 60 days. Four addltional patients from**
**Edinburgh, two in each p u p , were randomly assigned and followed up without pro-**
**tocol violations.**

**Volume 38, June** 1998 **TRANSFUSION** **525**


-----

**TABLE 1. Patient characteristics*** ~~ **DISCUSSION**

Threshold group Symptomatic group Total RBC transfusion is a commonly used
n = 42 n = 42 n=84

treatment that is expensive and in-

Hospital
Robert Wood Johnson University `7 (16.7%)` `8` `(19.1%)` `15` `(17.9%)` volves important risks. In this pilot
St. Peters Medical Center `23 (54.8%)` `22 (52.4%)` `45 (53.6%)` study, we successfully enrolled eld-
Miriam Hospital `10 (23.8%)` `10 (23.8%)` `20 (23.8%)` erly patients with hip fracture, and in
Royal Infirmary of Edinburgh `2 (4.8%)` `2 (4.8%)` `4` `(4.8%)`
Age (mean *standard deviation) `81.3 * 8.1` `83.3+10.8` `82.3 * 9.5` most patients the assigned transfu-

(range) `(50-94)` `(32-95)` `(32-95)` sion protocol was appropriately fol-

Gender (percentage female) `33 (78.6%)` `31 (73.8%)` `64 (76.2%)` lowed. The two transfusion strategy
Race (percentage white) `40 (95.2%)` `41 (97.6%)` `81 (96.4%)`
Cardiovascular disease `19 (45.2%)` `19 (45.2%)` `38 (45.2%)` groups had clinically important and

Coronary artery disease `12 (28.6%)` `12 (28.6%)` `24 (28.6%)` significant differences in the number
Congestive heart failure `6 (14.3%)` `6 (14.3%)` `12 (14.1%)` of RBC units transfused and in the
Peripheral vascular disease `3 (7.1%)` 1 `(2.4%)` `4 (4.8%)`
Cerebral vascular disease `6 (14.3%)` `10 (23.8%)` `16 (19.0%)` mean Hb levels during the hospital-
Chronic lung disease `10 (23.8%)` `6 (14.3%)` `16 (19.1%)` ization for hip fracture repair.
Diabetes treated Before the National Institutes of

(percentage receiving tablets or insulin) I `4 (9.5%)` `5` `(11.9%)` `9 (10.7%)`

History of dementia or confusion `13 (31.0%)` `17 (40.5%) 30 (35.7%)` Health 1988 consensus conference
Malnourished or cachectic `3 (7.1%)` `3` `(7.1%)` `6 (7.1%)` report on red cell transfusion^,^^ pa-
Preadmission residencet tients often received transfusion(s1
Community dwelling `33 (78.6%)` `31 (73.8%) 64 (76.2%)`
Nursing home `8` `(19.1%)` `1 1` `(26.2%) 19 (22.6%)` when the Hb level fell below 10 g per
Rehabilitation hospital `1` `(2.4%)` `0` `1` `(1.2%)` dL. However, the conference report
Type of hip fracture* concluded that patients should be
Femoral neck `13 (31.0%)` `17 (40.5%) 30 (35.7%)`
lntertrochanteric `29 (69.00/,) 26 (61.9%) 55 (65.5%)` given transfusion(s) on the basis of an
Subtrochanteric `5` `(1 1.9Yo)` `1` `(2.4%)` `6 (7.2%)` overall assessment of clinical status

ASA scores and symptoms rather than a thresh-

Mean `2.8 (k0.6)` `2.9 (k0.5)` `2.9 (k0.5)`
`1` `0` `0` `0` old Hb level, although there are few

**n**
**_L_** `1 1` `(26.2%)` `8` `(19.1%) 19 (22.6%)` data to support this or any other
`3` `28‘ (66.7%)` `31 (73.8%) 59 (70.2%)` transfusion strategy. Our trial was de-
```
           4 3 (7.1%) 3 (7.1%) 6 (7.1%)
```
`5` `0` `0` `0` signed to document the feasibility of
Anesthesia1 testing the clinical strategy suggested
General `25 (59.5%)` `26 (61.9%) 51 (60.7%)` in the consensus statement and
Regional `17 (40.5%)` `16 (38.1%) 33 (39.3%)`
Local `1` `(2.4%)` `0` `1` `(1.2%)` evaluate if patients would benefit
Surgical procedure from higher Hb levels.
Multiple screwdplate `33 (78.6?’0)` `26 (61.9%) 59 (70.2%)` The two transfusion strategies
Hemiarthroplasty `2 (4.8%)` `10 (23.8%) 12 (14.3%)`
Bipolar hemiarthroplasty `7 (16.7%)` `6 (14.3%) 13 (15.5%)` tested in this trial have an empirical
Total hip replacement `0` `0` `0` and theoretical basis. The rationale
Thromboembolism prophylaxis for the threshold transfusion strategy
Warfarin, low-molecular-weight

heparin, or intravenous heparin `15 (35.7%)` `14 (33.3%)` `29 (34.5%)` (keeping the postoperative Hb level

Pneumatic compression stockings `22 (52.4%)` `27 (64.3%)` `49 (58.3%)` >10 gldL) include the following. 1) A
Low -dose heparin `13 (31.0%)` `18 (42.9%)` `31 (36.9%)` recent study of 1958 Jehovah’s Witness
Aspirin `15` `(35.7%)` `12 (28.6%)` `27 (32.1%)`
Prerandomization transfusion `0.5 *I` `.O` `0.3 f 0.6` `0.4 + 0.8` patients undergoing surgery suggests
(mean *SD) `0` (median) `0` (median) `0` (median) that the risk of mortality and morbid-

`(0,l)Il` (osm `~0,0.5)n` ity begins to increase when the post-

Last preoperative Hb (mean * SD) `11.7 f 1.6` `11.6 * 1.0` `11.7 i 1.3`

Randomization Hb (mean * SD) `9.1 k0.6` `9.1 k0.6` `9.1 * 0.6` operative Hb falls below 10 g per dL,

All values represent the number and percentage of that group, unless noted otherwise. especially in patients with concomi-
###### t Community dwelling (home alone, home with others, retirement home [e.g., sheltered tant cardiovascular disease.12 2)
housing, congregate housing, halfway house, or board and care facility]), nursing home Transfused patients may have more
(e.g., skilled nursing facility, intermediate care facility, extended care facility, nursing home),
or other. “energy” and be better able to get out

###### * Five and two patients had more than one type of hip fracture in the threshold transfusion of bed (which reduces the risk of
group and symptomatic transfusion group, respectively. pneumonia and thromboembolism)
§ ASA Score: physical status patient; physical status 2 as patient with mild systemic disease; physical status 1 defined as normal, healthy `3 as patient` and may be able to work harder at re-
with severe systemic disease that limits activity but is not incapacitating; physical status 4 habilitation, which results in better
as patient with an incapacitating systemic disease that is a threat to life; and physical status functional status, reduced use of
```
         5 as moribund patient not expected to survive 24 hours, even with operation.
```
II One patient had both regional and local anesthesia. nursing home, and shorter length of
`1 lnterquartile range.` hospital stay. 3) Greater oxygen-cany-

**526** **TRANSFUSION** Volume 38, June 1998


-----

hemodilution, and blood substitutes.

**TABLE 2. Mean Hb levels and unlts of blood transfused**

The rationale for the use of each of

**After-enrollment** **Threshold group** **Symptomatic group**
**values** In = 42) **(n = 42)** **D value** these new treatments is to reduce al-

**Mean (*SD)** **Range** **Mean (iSD)** **Range** logeneic blood transfusion. When we

**Hb** have a clearer understanding of how
**Lowest** 9.4 (i 1.0) 7.3 -1 1.6 `8.8 (k1.2)` 5.6 -1 1.4 0.004' to treat patients with allogeneic blood
**Highest** 11.1 (i 0.9) 8.6 -14.0 10.0 (il.l) 7.9 -12.5 0.001' transfusions, we will be better able to
**Last** 10.7 (* 0.9) 8.0 -12.4 9.7 (i0.9) 7.9 -1 1.4 0.001'
**Units transfused** 2 **(median) (1,2)t** 0 -4 0 **(Median)(O,2)** 0 -6 0.001 * determine the appropriate indica-

              - **ttest.** tions for these new blood-manage-
###### t lnterquartile range ment strategies and drugs.
 * Wilcoxon's rank sum test. The results from a definitive trial

are likely to change RBC transfusion
practice. If the study shows that blood

###### -Threshold -Symptomatic

can be safelywithheld until the patient is symptomatic, that
should lead to more widespread acceptance and use of

###### 13 I

lower transfusion thresholds. Alternatively, if a definitive
trial demonstrates that higher Hb levels are needed to
maintain function or reduce mortality (as the trend in this
analysis showed), then current transfusion guidelines

**1** **I** **_I_** I **I** **t** would have to be updated. Large, simple, randomized clini-

cal trials are feasible and are needed to provide a scientific

###### 1 2 3 4 5 6 7to

basis for transfusion decisions.

###### 14 Days after randomization
**Pig. 2. Mean Hb levels each day after randomization, stratified**
**by assignment.**

ing capacity might result in fewer

**TABLE 3. Cllnlcal outcomes**

MIS and fewer episodes of congestive

**Threshold group Symptomatic group** **Total**

heart failure. The rationales for the **Outcome** **(n = 42)** In = 42) In = 841
symptomatic transfusion strategy are: **Death or inability to walk across**
`1) a cohort study of 8787 hip fracture` **room or** 10 feet without

**human assistance,** 19 (45.2%) 16 (39.0%) 35 (42.2%)

patients found no apparent effect of

**Mortality**

transfusion on mortality in patients **in-hospital** 0 0 0
with Hb levels as low as 8 g per dL, **30-dayt** 1 (2.4%) 1 (2.4%) 2 (2.4%)

**6O-dayS** 2 (4.8%) 5 (1 1.9%) 7 (8.3Yo)

even those with cardiovascular dis-

**MI**

easel3; 2) a lower Hb level would re- **Definite** `0` 0 0
duce blood viscosity, which might **Possible** `0` 1 (2.4%) 1 (1.2%)
lower the risk of fatal and **Stroke**

**Definite** 1 (2.4%) 0 1 (1.2%)

nonfatal thrombosis resulting in MI, **Possible** 0 0 0
stroke, and thromboembolism; 3) less **Pneumonia** 2 (4.8%) 0 2 (2.4%)
blood use would result in lower risk **Thromboembolism** 0 1 (2.4%) 1 (1.2%)

**Discharge destinations**

of transfusion-related complications, **Community dwelling** 2 (4.8%) 5 (1 1.9%) 7 (8.3%)
such as the immunomodulating ef- **Nursing home** 26 (61.9%) 19 (45.2%) 45 (53.6%)
fect of allogeneic blood, and of rare **Rehabilitation hospital** 14 (33.3%) 18 (42.9%) 32 (38.1%)

**Residence at 60 daysll**

viral infections; and 4) less blood use **Nursing home** 15 (35.7%) 14 (33.3%) 29 (34.5%)
might reduce the risk of transfusion **Community dwelling** 25 (59.5%) 22 (52.4%) 47 (59.5%)
complications resulting from human **Rehabilitation hospital** 0 1 (2.4%) 1 (1.2%)

**Death** 2 (4.8%) 5 (11.9%) 7 `(8.3%)`

errors, such as the use of mismatched **Length of** **stay** 6.4 k3.4) 6.3 Ii3.4) 6.3 k3.4)
blood. `Or inability or choice not to perform the task because of health problems, p = 0.57; symp-`
The options for blood manage- **tomatic n = 41 ; total n = 83**

###### t p = 1 .O (Fisher's exact).

ment are rapidly expanding and in-

###### * p = 0.43 (Fisher's exact); relative risk = 2.5; 95% CI, 0.5-12.2.

clude the use of autologous blood do- **p = 0.24 (chi-square).**
nation, erythropoietin, intraoperative II **p = 0.36 (chi-square).**

**Volume 38, June 1998** **TRANSFUSION** **527**


-----

**TABLE 4. Tasks that were performed without**
**human assistance'**

Threshold group Symptomatic group
Task fn = 421 f%) In = 42) f%) Total
Walk across room or **10 feet** **23** **(54.8%)** **25** **(61 .O%)t** **48** **(57.8%)**
Get into and out of bed **22** **(52.4%)** **21** **(51.2Yo)t** **43** **(51 .So/,)**
Walk one block on a level
surface **7** **(17.5%)$** **10** **(27.0%)§** **17** **(22.1 %)**
Climb 5 stairs **12** **(31.6%)11** **12** **(31.6%)11** **24** **(31 .So/,)**
Get in to and out of car **13** **(31.7%)t** **17** **(41.5%)t** `30` **(36.6%)**
Rise from armless chair **20** **(47.6%)** **15** **(39.5%)11** **35** **(43.8%)**
Put on pants **21** **(50.0%)** **14** **(34.1 Yo)t** **35** **(42.20,qn**
Put on shoes and sockson
both feet **18** **(42.9%)** **12** (30.0%)$ **30** **(36.6%)**
Get in and out of bath or
shower **10** **(24.4Yo)t** **8** `(20.0%)*` **18** **(22.2%)**
Take a shower or bath or
sponge bath **20** **(47.6%)** **20** **(48.8%)?** **40** **(48.2%)**

Patients who refused to answer question, responded don't know, or did not perform the activity for other reasons were considered missing for
question. Number of subjects included in analysis for each question are tn = 41; *n = 40; §n = 37; n = 38.
###### 1 p=0.14, all other p r0.2.

**ACKNOWLEDGMENTS** **10.** Johnson RG, Thurer RL, Kruskall MS, et al. Comparison of
The authors are extremely grateful to the orthopedic surgery two transfusion strategies after elective operations for myo-
residents and attending physicians, the blood transfusion ser- cardial revascularization. J Thorac Cardiovas Surg
vices, and the nursing staffs at our participating hospitals. **1992; 104~307- 14.**

**11.** Herbert PC, Wells G, Marshall J, et al. Transfusion require-

ments in critical care. JAMA 1995;273:1439-44.

###### REFERENCES

**12.** Carson JL, Duff A, Berlin JA, et al. Effect of anemia and car-

**1.** Wallace EL, Churchill WH, Surgenor DM, et al. Collection diovascular disease on surgical mortality and morbidity.

and transfusion of blood and blood components in the Lancet **1996;348:1055-60.**
United States, 1992. Transfusion **1995;35:802-12.** **13.** Carson JL, Duff A, Berlin JA, et al. Influence of perioperative

**2.** Forbes JM, Anderson MD, Anderson GF, et al. Blood trans- blood transfusion on postoperative mortality. JAMA

fusion costs: a multicenter study. Transfusion 1991; 31:318- **1998;279:199-205.**
**23.** Magaziner J, Zimmerman SI, Gruber-Baldini AL, et al. Proxy

**3.** Lubarsky DA, Han C, Bennett DH, et al. The hospital cost reporting in five areas of functional status: comparison with

(fiscal year 1991/ 1992) of a simple perioperative allogeneic self-reports and observations of performance. Am J
red blood cell transfusions during elective. surgery at Duke Epidemiol **1997;146:418-28.**
University. Anesth Analg 1994;790:629-37. Kenzora JE, Magaziner J, Hudson J, et al. Outcomes of treat-

**4.** Etchason J, Petz L, Keeler E, et al. The cost effectiveness of ment of intracapsular fractures by hemiarthroplasty in pa-

preoperative autologous blood donations. N Engl J Med tient over the age of 65. Clin Ortho 1998;348:51-8.

**1995;332:719-24.** **16.** White RH, McGahan JP, Daschbach, Hartling RP. Diagnosis

**5.** Dodd RY. The risk of transfusion-transmitted infection. N of deep-vein thrombosis using duplex ultrasound. Ann In-

Engl J Med **1992;327:419-21.** tern Med. 1989;111:297-304.

**6.** Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, The risk **17.** Huisman MV, Buller HR, ten Cate JW, Vreeken J. Serial im-

of transfusion-transmitted viral infections. Retrovirus Epi- pedance plethysmography for suspected deep venous
demiology Donor Study. N Engl J Med 1996;334:1685-90. thrombosis in outpatients: the Amsterdam General Practi-

**7.** Topley E, Fisher MR. The illness of trauma. Br J Clin Pract tioner Study. N Engl J Med 1986314:823-7.

**1956;1:770-6.** **18.** Kelley MA, Carson JL, Palevsky HI, Schwartz JS. Diagnosing

**_8._** Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect pulmonary embolism: new facts and strategies. Ann Intern

of early blood transfusion on gastrointestinal haemorrhage. Med **1991;114:300-6.**
Br J Surg 1986;73:783-5. **19.** Value of the ventilationlperfusion scan in acute pulmonary

**9.** Weisel RD, Charlesworth DC, Micklebourough LL, et al. embolism: Results of the prospective investigation of pul-

Limitations of blood conservation. J Thorac Cardiovasc monary embolism diagnosis (PIOPED). The PIOPED Inves-
Surg 1984;88:26-38. tigators. JAMA 1990;263:2753-9.

**528** **TRANSFUSION** Volume 38, June 1998


-----

**20.** Hull RD, Hirsh J, Carter CJ, et al. Diagnostic value of venti- Michael L. Terrin, MPH, Vice President, Maryland Medical

lation-perfusion lung scanning in patients with suspected Research Institute, Baltimore, MD.
pulmonary embolism. Chest **1985;88:819-28.** Franca H. Barton, MS, Statiistician, Maryland Medical Re-

**21.** Hull RD, Raskob GE, Coates G, et al. A new noninvasive search Institute.

strategy for patients with suspected pulmonary embolism. Roy Aaron, MD, Clinical Associate Professor of Orthope-
Arch Intern Med **1989;149:2549-55.** dics, Brown IJniversity School of Medicine, Miriam Hospital,

**22.** Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for Providence, HI.

nosocomial infections, 1988. Am J Infect Control A. Gerson Greenburg, MD, Professor of Surgery, Brown

**1988; 16: 128-40.** University School of Medicine, and Surgeon-in-Chief, Miriam

**23.** Dripps RD, Larnont A, Eckenhoff JE. The role of anesthesia Hospital.

in surgical mortality. JAMA 1961;178:261-6. David A. Heck, MD, Professor, Department of Orthopaedic

**24.** New classification of physical status. Anesthesiology Surgery, Indiana University, Indianapolis, IN.

**1963;24:111.** Jay Magaziner, PhD, Associate Professor, Department of

**25.** Feinberg SE. The analysis of cross classified data. Cam- Epidemiology and Preventive Medicine, University of Maryland,

bridge, MA: The MIT Press, 1977:9. Baltimore, MD.

**26.** Hays WL. Statistics for the social sciences. 2nd ed. New Frances E. Merlino, RN, Research Nurse, Division of Gen-

York Holt, Rinehardt, and Winston, 1973:404-10. eral Internal Medicine, Department of Medicine, University of

**27.** Conover WJ. Practical non-parametric statistics. 2nd ed. Medicine and Dentistry of New Jersey.

New YorkJohn Wiley and Sons, 1980. Gail Bunce, RN, CNP Staff Nurse, Department of Surgery,

**28.** Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologi- Miriam Hospital.

cal Research: principles and quantitative methods. Brian McClelland, MD, Director, Department of Transfu-
Belmont, CA: Wadsworth, 1982:299. sion Medicine, University of Edinburgh, The Royal Infirmary of

**29.** Perioperative red blood cell transfusion. Consensus confer- Edinburgh, Edinburgh, Scotland.

ence. JAMA 1988;260:2700-3. Amy Duff, MHS, Teaching and Research Specialist, Division

of General Internal Medicine, Department of Medicine, Univer-
sity of Medicine and Dentistry of New Jersey.

**AUTHORS** Helaine Noveck, MPH, Teaching and Research Specialist,

Jeffrey L. Carson, MD, Richard C. Reynolds Professor of Medi- Division of General Internal Medicine, Department of Medicine,
cine and Chief, the Division of General Internal Medicine, De- University of Medicine and Dentistry of New Jersey.
partment of Medicine, University of Medicine and Dentistry of
New Jersey, Robert Wood Johnson Medical School, 125
Patterson Street, New Brunswick, NJ 08903. [Reprint requests]

Volume 38, June 1998 **TRANSFUSION** 529


-----

